Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranolazine for the Treatment of sYmPtoms of PaLpitations in patiEnts With Ischemic Heart Disease - The RYPPLE Trial

NCT01495520 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT01495520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01495520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranolazine for the Treatment of sYmPtoms of PaLpitations in patiEnts With Ischemic Heart Disease - The RYPPLE Trial
Lead sponsor
University of Roma La Sapienza
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2016
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease